- Martin Cormican, medical microbiologist1,
- Akke Vellinga, epidemiologist1
- 1School of Medicine (General Practice and Bacteriology), National University of Ireland Galway, Galway, Republic of Ireland
- martin.cormican{at}hse.ie
Paccaud emphasises economic incentives for new antibiotic discovery to tackle antibiotic resistance.1 An ecological perspective suggests that new drug discovery may not make a major contribution.
The ideal target for antibiotic action is a crucial step in bacterial physiology with no parallel in mammalian cells—for example, penicillin targets a step in cell wall synthesis. Because there …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record








Social bookmarking